1,2,8-三羟基-6-甲氧基-3-甲基蒽-9,10-二酮 | 14717-90-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 中文名称: 1,2,8-三羟基-6-甲氧基-3-甲基蒽-9,10-二酮
• 英文名称: 6-O-methylalaternin
• 英文别名: 1,2,8-Trihydroxy-6-methoxy-3-methylanthraquinone；1,2,8-trihydroxy-6-methoxy-3-methylanthracene-9,10-dione
• CAS: 14717-90-9
• 化学式: C₁₆H₁₂O₆
• 分子量: 300.268
• InChiKey: IOPGGNYCFGEWPF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  22
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  104
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  Alterporriol A 生成 1,2,8-三羟基-6-甲氧基-3-甲基蒽-9,10-二酮
  参考文献：
  名称：

  SUEMITSU, RIKISAKU;YAMAMOTO, TOSHINARI;MIYAL, TAKESHI;UESHIMA, TOSHIBUMI, PHYTOCHEMISTRY, 26,(1987) N 12, 3221-3224

  摘要：

  DOI：

文献信息

• Alterporriol C: A modified bianthraquinone from Alternaria porri
  作者：Rikisaku Suemitsu、Toshibumi Ueshima、Toshinari Yamamoto、Satoshi Yanagawase

  DOI：10.1016/0031-9422(88)80036-0

  日期：1988.1

  The spent growth medium and mycelia of Alternaria porri afforded a novel anthraquinone named alterporriol C, whose structure was determined by spectroscopic methods as well as by degradation to known compounds. Alterporriol C was found to be an .alpha.,.beta.''-bianthraquinone derived from macrosporin and altersolanol A.
• SUEMITSU, RIKISAKU;UESHIMA, TOSHIBUMI;YAMAMOTO, TOSHINARI;YANAGAWASE, SAT+, PHYTOCHEMISTRY, 27,(1988) N 10, C. 3251-3254
  作者：SUEMITSU, RIKISAKU、UESHIMA, TOSHIBUMI、YAMAMOTO, TOSHINARI、YANAGAWASE, SAT+

  DOI：——

  日期：——
• TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION
  申请人：ETH Zurich

  公开号：EP3801507A2

  公开（公告）日：2021-04-14
• METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
  申请人：Haggerty Timothy J.

  公开号：US20140335050A1

  公开（公告）日：2014-11-13

  The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
• SUEMITSU, RIKISAKU;YAMAMOTO, TOSHINARI;MIYAL, TAKESHI;UESHIMA, TOSHIBUMI, PHYTOCHEMISTRY, 26,(1987) N 12, 3221-3224
  作者：SUEMITSU, RIKISAKU、YAMAMOTO, TOSHINARI、MIYAL, TAKESHI、UESHIMA, TOSHIBUMI

  DOI：——

  日期：——